BC Innovations | Aug 1, 2013
Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Hyaluronan synthase 2 (HAS2); hyaluronidase 2 (HYAL2) In vitro and rodent studies suggest extremely high molecular mass hyaluronan (HMM-HA) could...
BC Week In Review | Apr 16, 2001
Company News

Fred Hutchinson Cancer Research Center other research news

Researchers published in the Proceedings of the National Academy of Sciences that the human tumor suppressor candidate HYAL2 gene product, which mediates cell entry of Jaagsietke sheep retrovirus (JRSV), is responsible for the oncogenic activity...
Items per page:
1 - 2 of 2